FATE - Fate Therapeutics GAAP EPS of -$0.44 misses by $0.02, revenue of $1.86M beats by $0.29M March, 05 2025 04:51 PM Fate Therapeutics Inc. 2025-03-05 16:51:06 ET More on Fate Therapeutics Fate Therapeutics Has Promising Off-The-Shelf Cell Therapies While Looking Cheap Seeking Alpha’s Quant Rating on Fate Therapeutics Historical earnings data for Fate Therapeutics Financial information for Fate Therapeutics For further details see: Fate Therapeutics GAAP EPS of -$0.44 misses by $0.02, revenue of $1.86M beats by $0.29M